EFFECTIVENESS OF CARBOPLATIN, ETOPOSIDE, AND BLEOMYCIN COMBINATION CHEMOTHERAPY IN GOOD-PROGNOSIS METASTATIC TESTICULAR NONSEMINOMATOUS GERM-CELL TUMORS

被引：106

作者：

HORWICH, A ^{[1
]}

DEARNALEY, DP ^{[1
]}

NICHOLLS, J ^{[1
]}

JAY, G ^{[1
]}

MASON, M ^{[1
]}

HARLAND, S ^{[1
]}

PECKHAM, MJ ^{[1
]}

HENDRY, WF ^{[1
]}

机构：

[1] ROYAL MARSDEN HOSP & INST CANC RES,TESTICULAR TUMOUR UNIT,SUTTON,SURREY,ENGLAND

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1991年 / 9卷 / 01期

关键词：

TERM FOLLOW-UP; RENAL-FUNCTION; MALIGNANT TERATOMA; CIS-PLATINUM; MULTIVARIATE-ANALYSIS; COMBINED MANAGEMENT; ROYAL-MARSDEN; POOR RISK; CISPLATIN; CANCER;

D O I：

10.1200/JCO.1991.9.1.62

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：62 / 69

页数：8

共 48 条

[1] COMPARISON OF CRITERIA FOR ASSIGNING GERM-CELL TUMOR PATIENTS TO GOOD RISK AND POOR RISK STUDIES [J].

BAJORIN, D ;

KATZ, A ;

CHAN, E ;

GELLER, N ;

VOGELZANG, N ;

BOSL, GJ .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (05) :786-792

[2] PROGNOSTIC FACTORS FOR FAVORABLE OUTCOME IN DISSEMINATED GERM-CELL TUMORS [J].

BIRCH, R ;

WILLIAMS, S ;

CONE, A ;

EINHORN, L ;

ROARK, P ;

TURNER, S ;

GRECO, FA .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (03) :400-407

[3]

BOSL GJ, 1983, CANCER RES, V43, P3403

[4] VAB-6 - AN EFFECTIVE CHEMOTHERAPY REGIMEN FOR PATIENTS WITH GERM-CELL TUMORS [J].

BOSL, GJ ;

GLUCKMAN, R ;

GELLER, NL ;

GOLBEY, RB ;

WHITMORE, WF ;

HERR, H ;

SOGANI, P ;

MORSE, M ;

MARTINI, N ;

BAINS, M ;

MCCORMACK, P .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (10) :1493-1499

[5] A RANDOMIZED TRIAL OF ETOPOSIDE + CISPLATIN VERSUS VINBLASTINE + BLEOMYCIN + CISPLATIN + CYCLOPHOSPHAMIDE + DACTINOMYCIN IN PATIENTS WITH GOOD-PROGNOSIS GERM-CELL TUMORS [J].

BOSL, GJ ;

GELLER, NL ;

BAJORIN, D ;

LEITNER, SP ;

YAGODA, A ;

GOLBEY, RB ;

SCHER, H ;

VOGELZANG, NJ ;

AUMAN, J ;

CAREY, R ;

FAIR, WR ;

HERR, H ;

MORSE, M ;

SOGANI, P ;

WHITMORE, W .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (08) :1231-1238

[6] CARBOPLATIN DOSAGE - PROSPECTIVE EVALUATION OF A SIMPLE FORMULA BASED ON RENAL-FUNCTION [J].

CALVERT, AH ;

NEWELL, DR ;

GUMBRELL, LA ;

OREILLY, S ;

BURNELL, M ;

BOXALL, FE ;

SIDDIK, ZH ;

JUDSON, IR ;

GORE, ME ;

WILTSHAW, E .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (11) :1748-1756

[7] PHASE-I STUDIES WITH CARBOPLATIN AT THE ROYAL-MARSDEN-HOSPITAL [J].

CALVERT, AH ;

HARLAND, SJ ;

NEWELL, DR ;

SIDDIK, ZH ;

HARRAP, KR .

CANCER TREATMENT REVIEWS, 1985, 12 :51-57

[8]

CHANTLER C, 1969, CLIN SCI, V37, P169

[9]

DENTINO M, 1978, CANCER-AM CANCER SOC, V41, P1274, DOI 10.1002/1097-0142(197804)41:4<1274::AID-CNCR2820410410>3.0.CO

[10]

2-F

← 1 2 3 4 5 →